Anti-ENO1 + ENO2 + ENO3 antibody [EPR18407] - BSA and Azide free
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal ENO1 antibody. Carrier free. Suitable for ICC/IF, WB, Flow Cyt (Intra) and reacts with Mouse, Human, Rat, Recombinant full length protein - Human samples. Cited in 1 publication.
View Alternative Names
ENO1L1, MBPB1, MPB1, ENO1, Alpha-enolase, 2-phospho-D-glycerate hydro-lyase, C-myc promoter-binding protein, Enolase 1, MBP-1, MPB-1, Non-neural enolase, Phosphopyruvate hydratase, Plasminogen-binding protein, NNE
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-ENO1 + ENO2 + ENO3 antibody [EPR18407] - BSA and Azide free (AB250997)
This data was developed using ab189891, the same antibody clone in a different buffer formulation.
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized HeLa (Human epithelial cell line from cervix adenocarcinoma) cells labeling ENO1 + ENO2 + ENO3 with ab189891 at 1/500 dilution, followed by Goat Anti-Rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green).
Confocal image showing mostly cytoplasmic staining on Hela cells.
The nuclear counterstain is DAPI (blue).
Tubulin is detected with Anti-alpha Tubulin - Loading Control (ab7291) at 1/1000 dilution and Goat Anti-Mouse IgG (AlexaFluor®594) preadsorbed (ab150120) at 1/1000 dilution (red).
The negative controls are as follows : -
-ve control 1 : ab189891 at 1/500 dilution followed by ab150120 at 1/1000 dilution.
-ve control 2 : ab7291 at 1/1000 dilution followed by ab150077 at 1/1000 dilution.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-ENO1 + ENO2 + ENO3 antibody [EPR18407] - BSA and Azide free (AB250997)
This data was developed using ab189891, the same antibody clone in a different buffer formulation.
Intracellular flow cytometric analysis of 4% paraformaldehyde-fixed NIH/3T3 (Mouse embryonic fibroblast cell line) labeling ENO1 + ENO2 + ENO3 with ab189891 at 1/70 dilution (red) compared with a Rabbit IgG,monoclonal - Isotype control (ab172730) (black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (blue). Goat anti Rabbit IgG (Alexa Fluor® 488) at 1/500 dilution was used as the secondary antibody.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-ENO1 + ENO2 + ENO3 antibody [EPR18407] - BSA and Azide free (AB250997)
This data was developed using ab189891, the same antibody clone in a different buffer formulation.
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized NIH/3T3 (Mouse embryonic fibroblast cell line) cells labeling ENO1 + ENO2 + ENO3 with ab189891 at 1/500 dilution, followed by Goat Anti-Rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green).
Confocal image showing mostly cytoplasmic staining on NIH/3T3 cells.
The nuclear counterstain is DAPI (blue).
Tubulin is detected with Anti-alpha Tubulin antibody -Loading Control (ab7291) at 1/1000 dilution and Goat Anti-Mouse IgG (AlexaFluor®594) preadsorbed (ab150120) at 1/1000 dilution (red).
The negative controls are as follows : -
-ve control 1 : ab189891 at 1/500 dilution followed by ab150120 at 1/1000 dilution.
-ve control 2 : ab7291 at 1/1000 dilution followed by ab150077 at 1/1000 dilution.
- WB
Supplier Data
Western blot - Anti-ENO1 + ENO2 + ENO3 antibody [EPR18407] - BSA and Azide free (AB250997)
This data was developed using ab189891, the same antibody clone in a different buffer formulation.
Blocking and dilution buffer : 5% NFDM/TBST.
Human ENO1 full length recombinant protein (ab89248) contains aa1-434. Human ENO2 full length recombinant protein contains aa1-434 with a His-Tag®. Human ENO3 full length recombinant protein (ab113127) contains aa1-434 with a His-Tag®. Human ENO2 full length recombinant protein was made in-house.
All lanes:
Western blot - Anti-ENO1 + ENO2 + ENO3 antibody [EPR18407] (<a href='/en-us/products/primary-antibodies/eno1-eno2-eno3-antibody-epr18407-ab189891'>ab189891</a>) at 1/1000 dilution
Lane 1:
Human ENO1 full length recombinant protein at 0.02 µg
Lane 2:
Human ENO2 full length recombinant protein at 0.02 µg
Lane 3:
Human ENO3 full length recombinant protein at 0.02 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 47 kDa
Observed band size: 47 kDa
false
Exposure time: 5s
- WB
Supplier Data
Western blot - Anti-ENO1 + ENO2 + ENO3 antibody [EPR18407] - BSA and Azide free (AB250997)
This data was developed using ab189891, the same antibody clone in a different buffer formulation.
Blocking and dilution buffer : 5% NFDM/TBST.
Exposure times : Lanes 1-2 : 5 seconds; Lane 3 : 15 seconds.
All lanes:
Western blot - Anti-ENO1 + ENO2 + ENO3 antibody [EPR18407] (<a href='/en-us/products/primary-antibodies/eno1-eno2-eno3-antibody-epr18407-ab189891'>ab189891</a>) at 1/1000 dilution
Lane 1:
Human fetal heart lysate at 10 µg
Lane 2:
Human fetal kidney lysate at 10 µg
Lane 3:
Human fetal spleen lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG Peroxidase Conjugate, specific to the non-reduced form of IgG at 1/10000 dilution
Predicted band size: 47 kDa
Observed band size: 47 kDa
false
- WB
Supplier Data
Western blot - Anti-ENO1 + ENO2 + ENO3 antibody [EPR18407] - BSA and Azide free (AB250997)
This data was developed using ab189891, the same antibody clone in a different buffer formulation.
Blocking and dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-ENO1 + ENO2 + ENO3 antibody [EPR18407] (<a href='/en-us/products/primary-antibodies/eno1-eno2-eno3-antibody-epr18407-ab189891'>ab189891</a>) at 1/5000 dilution
Lane 1:
HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg
Lane 2:
Jurkat (Human T cell leukemia cell line from peripheral blood) whole cell lysate at 20 µg
Lane 3:
MCF7 (Human breast adenocarcinoma cell line) whole cell lysate at 20 µg
Lane 4:
A431 (Human epidermoid carcinoma cell line) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 47 kDa
Observed band size: 47 kDa
false
Exposure time: 3s
- WB
Supplier Data
Western blot - Anti-ENO1 + ENO2 + ENO3 antibody [EPR18407] - BSA and Azide free (AB250997)
This data was developed using ab189891, the same antibody clone in a different buffer formulation.
Blocking and dilution buffer : 5% NFDM/TBST.
Exposure time : Lanes 1-4 : 5 seconds; Lanes 5-7 : 1 second.
Lanes 1 - 4:
Western blot - Anti-ENO1 + ENO2 + ENO3 antibody [EPR18407] (<a href='/en-us/products/primary-antibodies/eno1-eno2-eno3-antibody-epr18407-ab189891'>ab189891</a>) at 1/1000 dilution
Lanes 5 - 7:
Western blot - Anti-ENO1 + ENO2 + ENO3 antibody [EPR18407] (<a href='/en-us/products/primary-antibodies/eno1-eno2-eno3-antibody-epr18407-ab189891'>ab189891</a>) at 1/5000 dilution
Lane 1:
Mouse brain tissue lysate at 10 µg
Lane 2:
Mouse heart tissue lysate at 10 µg
Lane 3:
Rat brain tissue lysate at 10 µg
Lane 4:
Rat heart tissue lysate at 10 µg
Lane 5:
C6 (Rat glial tumor cell line) whole cell lysate at 10 µg
Lane 6:
RAW 264.7 (Mouse macrophage cell line transformed with Abelson murine leukemia virus) whole cell lysate at 10 µg
Lane 7:
NIH/3T3 (Mouse embryonic fibroblast cell line) whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/10000 dilution
Predicted band size: 47 kDa
Observed band size: 47 kDa
false
Related conjugates and formulations (1)
-
Anti-ENO1 + ENO2 + ENO3 antibody [EPR18407]
Reactivity data
Product details
ab250997 is the carrier-free version of ab189891.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The enolase family of isoenzymes acts as multifunctional catalysts and has roles beyond glycolysis. ENO1 serves as a plasminogen receptor on cell surfaces assisting in tissue remodeling and immune response. ENO2 often referred to as neuron-specific enolase (NSE) functions importantly in neural development and tumor cell metabolism. ENO3 or muscle-specific enolase contributes to muscle metabolism and energy turnover. While these proteins individually carry out essential tasks they also form a complex that facilitates efficient energy production and cellular regulation.
Pathways
The enolase enzymes integrate in the glycolytic and gluconeogenesis pathways central to energy metabolism. Glycolysis involves other key proteins like hexokinase and phosphofructokinase cooperating for glucose breakdown and energy release. In gluconeogenesis the enolases help generate glucose from non-carbohydrate sources important during fasting or intense exercise. Their activity along with related proteins impacts the efficiency and regulation of energy metabolism pathways.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Genes 14: PubMed37239471
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com